See more : ERP Soft Systems Limited (ERPSOFT.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Pacific Shuanglin Bio-pharmacy Co., LTD (000403.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Pacific Shuanglin Bio-pharmacy Co., LTD, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Daytona Corporation (7228.T) Income Statement Analysis – Financial Results
- COCOLIVE INC (137A.T) Income Statement Analysis – Financial Results
- Jiangsu Leili Motor Co., Ltd (300660.SZ) Income Statement Analysis – Financial Results
- Cotinga Pharmaceuticals Inc. (COTQF) Income Statement Analysis – Financial Results
- Jess-link Products Co., Ltd. (6197.TW) Income Statement Analysis – Financial Results
Pacific Shuanglin Bio-pharmacy Co., LTD (000403.SZ)
About Pacific Shuanglin Bio-pharmacy Co., LTD
Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in the biochemical engineering, pharmaceutical industry equipment, and medical materials businesses in China. Its lead products include human serum albumin, human immunoglobulin, intravenous human immunoglobulin (PH4), human rabies immunoglobulin, hepatitis B human immunoglobulin, tetanus human immunoglobulin, tianqi analgesic cream, musk herd cream, musk bone paste, anti-inflammatory analgesic cream, dieshangling plasters, and medical gauzes. The company is also involved in the development of porcine pulmonary surfactants, shaqifang compounds, a1-protease inhibitors, human coagulation factor VIII products, and human fibrinogens. In addition, it engages in the investment, consultation, and technology promotion of pharmaceutical and biotechnology development projects; real estate development; and electronic product information consultation, as well as in the provision of electricity. The company was formerly known as Southern Shuanglin Bio-pharmacy Co., Ltd. and changed its name to Pacific Shuanglin Bio-pharmacy Co., Ltd. in April 2021. Pacific Shuanglin Bio-pharmacy Co., Ltd. is based in Taiyuan, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.33B | 2.41B | 1.97B | 1.05B | 915.66M | 859.84M | 685.38M | 567.44M | 500.27M | 489.50M | 477.72M | 469.82M | 461.07M | 545.67M | 465.91M | 578.80M | 645.03M | 674.90M | 742.95M | 669.81M | 651.81M | 467.96M | 422.25M | 381.18M | 349.95M | 191.57M | 157.45M | 143.33M | 141.89M |
| Cost of Revenue | 1.13B | 1.15B | 1.06B | 537.36M | 436.41M | 401.33M | 294.84M | 249.57M | 235.43M | 210.05M | 190.68M | 178.75M | 152.06M | 242.25M | 248.67M | 416.16M | 481.67M | 558.55M | 605.23M | 535.22M | 501.31M | 326.37M | 256.88M | 211.35M | 211.79M | 125.76M | 111.78M | 105.12M | 105.92M |
| Gross Profit | 1.20B | 1.25B | 908.43M | 512.58M | 479.24M | 458.52M | 390.54M | 317.87M | 264.84M | 279.45M | 287.04M | 291.07M | 309.01M | 303.43M | 217.24M | 162.64M | 163.36M | 116.35M | 137.72M | 134.59M | 150.50M | 141.58M | 165.37M | 169.83M | 138.16M | 65.81M | 45.67M | 38.21M | 35.97M |
| Gross Profit Ratio | 51.48% | 52.13% | 46.07% | 48.82% | 52.34% | 53.33% | 56.98% | 56.02% | 52.94% | 57.09% | 60.08% | 61.95% | 67.02% | 55.61% | 46.63% | 28.10% | 25.33% | 17.24% | 18.54% | 20.09% | 23.09% | 30.26% | 39.16% | 44.55% | 39.48% | 34.35% | 29.01% | 26.66% | 25.35% |
| Research & Development | 79.69M | 75.36M | 35.63M | 11.00M | 14.73M | 28.59M | 29.39M | 26.77M | 24.13M | 19.09M | 26.88M | 16.31M | 28.46M | 28.38M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 50.81M | 39.16M | 43.90M | 27.23M | 22.55M | 51.01M | 74.29M | 52.84M | 42.17M | 26.81M | 35.66M | 35.50M | 26.28M | 52.07M | 121.24M | 82.47M | 74.63M | 75.89M | 530.75M | 275.02M | 61.35M | 55.16M | 50.08M | 30.86M | 37.45M | 14.36M | 12.90M | 12.59M | 12.78M |
| Selling & Marketing | 260.95M | 399.57M | 229.27M | 158.62M | 144.64M | 146.42M | 78.15M | 49.55M | 11.12M | 6.70M | 17.67M | 16.20M | 21.05M | 22.32M | 21.72M | 27.42M | 31.67M | 40.11M | 47.28M | 32.34M | 18.33M | 15.94M | 11.30M | 10.41M | 11.23M | 6.57M | 7.34M | 4.19M | 3.56M |
| SG&A | 427.33M | 438.73M | 273.17M | 185.85M | 167.20M | 197.43M | 152.44M | 102.39M | 53.29M | 33.51M | 53.33M | 51.71M | 47.33M | 74.38M | 142.96M | 109.89M | 106.30M | 116.00M | 578.03M | 307.35M | 79.67M | 71.10M | 61.37M | 41.27M | 48.67M | 20.92M | 20.24M | 16.79M | 16.34M |
| Other Expenses | 0.00 | 128.25M | 150.04M | 92.83M | 90.84M | 107.95M | 87.36M | 13.64M | 55.04M | 47.60M | 113.19M | -25.75M | -20.19M | 23.60M | -712.56K | 200.02M | 117.05M | 14.86M | -82.87M | 14.38M | 4.00M | 10.55M | 20.23M | 23.78M | 25.83M | 338.64K | 3.69M | 7.94M | -1.53M |
| Operating Expenses | 503.66M | 642.34M | 458.83M | 289.68M | 272.77M | 333.97M | 269.19M | 227.85M | 158.39M | 134.12M | 152.92M | 136.43M | 143.37M | 163.52M | 145.03M | 111.87M | 107.64M | 117.73M | 580.88M | 308.99M | 80.59M | 72.36M | 62.33M | 42.17M | 50.14M | 22.15M | 21.25M | 17.52M | 17.35M |
| Cost & Expenses | 1.63B | 1.79B | 1.52B | 827.04M | 709.18M | 735.29M | 564.03M | 477.42M | 393.83M | 344.16M | 343.60M | 315.18M | 295.43M | 405.77M | 393.70M | 528.03M | 589.32M | 676.27M | 1.19B | 844.21M | 581.90M | 398.74M | 319.20M | 253.52M | 261.93M | 147.90M | 133.02M | 122.64M | 123.28M |
| Interest Income | 67.68M | 65.18M | 58.59M | 18.31M | 1.17M | 528.53K | 490.59K | 139.46K | 231.72K | 106.55K | 102.15K | 114.46K | 138.53K | 211.52K | 139.34K | 151.62K | 146.93K | 133.61K | 353.16K | 3.41M | 2.02M | 1.33M | 1.75M | -0.90 | -0.51 | -0.68 | -0.06 | -0.88 | -0.18 |
| Interest Expense | 8.41M | 12.03M | 9.99M | 19.31M | 21.71M | 26.04M | 28.28M | 30.88M | 31.26M | 37.05M | 70.61M | 34.42M | 21.94M | 20.55M | 41.89M | 46.97M | 86.98M | 98.74M | 85.35M | 51.63M | 36.53M | 29.33M | 21.38M | 12.80M | 14.17M | 9.12M | 6.94M | 9.08M | 4.72M |
| Depreciation & Amortization | 146.08M | 130.81M | 123.15M | 55.72M | 54.80M | 58.64M | 56.90M | 53.02M | 47.67M | 45.99M | 30.22M | 30.43M | 33.66M | 34.07M | 53.80M | 54.45M | 63.07M | 69.16M | 74.46M | 52.81M | 30.67M | 23.71M | 21.32M | 12.80M | 8.41M | 6.71M | 3.09M | 763.72K | 5.78M |
| EBITDA | 844.18M | 803.47M | 593.77M | 283.87M | 237.17M | 166.52M | 129.69M | 147.47M | 172.48M | 230.88M | 159.67M | 159.41M | 88.63M | 68.90M | 74.41M | 301.41M | 235.56M | 81.93M | -460.83M | -119.45M | 103.82M | 103.16M | 144.87M | 140.38M | 96.43M | 47.81M | 24.42M | 20.69M | 18.61M |
| EBITDA Ratio | 36.25% | 33.47% | 31.57% | 27.18% | 29.42% | 20.94% | 19.12% | 27.53% | 35.62% | 55.11% | 43.33% | 33.93% | 38.87% | 33.60% | 26.81% | 52.62% | 36.58% | 11.08% | -62.03% | -17.83% | 15.93% | 22.04% | 34.31% | 36.87% | 27.55% | 26.30% | 15.51% | 14.43% | 13.12% |
| Operating Income | 695.19M | 663.43M | 460.43M | 220.30M | 180.04M | 130.99M | 83.64M | 55.15M | 68.32M | 100.25M | 58.87M | 53.13M | 53.22M | -8.92M | -20.38M | -37.19K | -31.54M | -103.42M | -540.00M | -225.94M | 35.03M | 43.29M | 83.71M | 122.72M | 87.61M | 34.40M | 21.33M | 19.93M | 12.84M |
| Operating Income Ratio | 29.85% | 27.58% | 23.35% | 20.98% | 19.66% | 15.23% | 12.20% | 9.72% | 13.66% | 20.48% | 12.32% | 11.31% | 11.54% | -1.64% | -4.37% | -0.01% | -4.89% | -15.32% | -72.68% | -33.73% | 5.37% | 9.25% | 19.82% | 32.19% | 25.04% | 17.96% | 13.55% | 13.90% | 9.05% |
| Total Other Income/Expenses | -7.08M | -3.04M | -2.42M | -3.10M | 8.97M | -35.26M | -39.21M | 4.89M | 23.94M | 47.59M | 29.77M | -123.26M | -114.07M | -57.21M | -80.03M | 200.02M | 29.80M | -82.27M | -80.64M | -68.47M | 1.59M | 6.83M | 18.46M | 12.25M | 10.74M | 331.68K | 3.05M | -185.18K | -336.02K |
| Income Before Tax | 688.11M | 660.39M | 458.01M | 217.19M | 189.01M | 97.59M | 44.42M | 68.78M | 92.26M | 147.84M | 88.64M | 27.36M | 33.03M | 14.27M | -21.28M | 199.99M | 85.51M | -93.13M | -620.64M | -223.89M | 36.61M | 50.12M | 102.17M | 144.89M | 98.36M | 34.73M | 24.38M | 19.74M | 12.50M |
| Income Before Tax Ratio | 29.55% | 27.46% | 23.23% | 20.69% | 20.64% | 11.35% | 6.48% | 12.12% | 18.44% | 30.20% | 18.55% | 5.82% | 7.16% | 2.62% | -4.57% | 34.55% | 13.26% | -13.80% | -83.54% | -33.43% | 5.62% | 10.71% | 24.20% | 38.01% | 28.11% | 18.13% | 15.49% | 13.77% | 8.81% |
| Income Tax Expense | 76.64M | 72.70M | 66.47M | 34.51M | 31.17M | 22.65M | 29.18M | 24.46M | 25.42M | 40.91M | 24.63M | 24.83M | 29.08M | 25.18M | 18.72M | 14.15M | 10.58M | 8.13M | 1.22M | 3.26M | 6.51M | 2.78M | 349.79K | 1.19M | 3.29M | 7.29M | 3.70M | 3.14M | 4.15M |
| Net Income | 612.11M | 587.13M | 391.06M | 185.97M | 160.45M | 79.98M | 15.24M | 53.90M | 77.56M | 122.52M | 70.28M | 32.57M | 40.71M | 29.23M | 2.33M | 202.01M | 34.61M | -76.40M | -521.48M | -193.18M | 24.00M | 44.92M | 78.91M | 119.07M | 80.17M | 23.80M | 20.68M | 16.60M | 8.36M |
| Net Income Ratio | 26.29% | 24.41% | 19.83% | 17.71% | 17.52% | 9.30% | 2.22% | 9.50% | 15.50% | 25.03% | 14.71% | 6.93% | 8.83% | 5.36% | 0.50% | 34.90% | 5.37% | -11.32% | -70.19% | -28.84% | 3.68% | 9.60% | 18.69% | 31.24% | 22.91% | 12.42% | 13.13% | 11.58% | 5.89% |
| EPS | 0.84 | 0.80 | 0.55 | 0.38 | 0.33 | 0.15 | 0.03 | 0.09 | 0.14 | 0.23 | 0.13 | 0.06 | 0.10 | 0.07 | 0.01 | 0.49 | 0.08 | -0.18 | -1.23 | -0.46 | 0.06 | 0.11 | 0.21 | 0.28 | 0.31 | 0.10 | 0.09 | 0.13 | 0.02 |
| EPS Diluted | 0.84 | 0.80 | 0.55 | 0.38 | 0.33 | 0.15 | 0.03 | 0.09 | 0.14 | 0.23 | 0.13 | 0.06 | 0.10 | 0.07 | 0.01 | 0.49 | 0.08 | -0.18 | -1.23 | -0.46 | 0.06 | 0.11 | 0.21 | 0.28 | 0.31 | 0.10 | 0.09 | 0.13 | 0.02 |
| Weighted Avg Shares Out | 728.64M | 730.72M | 705.51M | 489.21M | 489.21M | 532.31M | 527.15M | 532.14M | 540.91M | 531.63M | 527.83M | 530.05M | 418.35M | 407.65M | 454.66M | 415.22M | 422.37M | 415.27M | 422.37M | 422.37M | 422.37M | 422.37M | 422.37M | 422.37M | 422.37M | 422.37M | 422.37M | 422.37M | 422.37M |
| Weighted Avg Shares Out (Dil) | 728.64M | 730.99M | 707.17M | 490.29M | 489.21M | 532.31M | 527.15M | 532.14M | 540.91M | 531.63M | 527.83M | 530.05M | 418.35M | 407.65M | 454.66M | 415.22M | 422.37M | 415.27M | 422.37M | 422.37M | 422.37M | 422.37M | 422.37M | 422.37M | 422.37M | 422.37M | 422.37M | 422.37M | 422.37M |
Source: https://incomestatements.info
Category: Stock Reports